Title
Category
Credits
Event date
Cost
- Sleep
- Diagnostic Tools
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Drs Rosenberg and Krystal identify key steps in the diagnosis and treatment of insomnia disorder.
- Bipolar Disorder
- Depression
- Antidepressants
- Antipsychotics
- Child and Adolescent Psychiatry
- Diagnostic Tools
- Mood Disorders
- Patient/Physician Communication
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
- Depression
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Closer monitoring of symptoms through measurement-based care and setting symptom remission as a goal can help improve outcomes for adults with depression.
- Anticonvulsants
- Epilepsy
- Neurology
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Drs Detyniecki and Penovich identify the need for emergency seizure response plans and the new rescue treatment options that may easily be used by patients with epilepsy and their caregivers.
- Hepatitis
- Medical Conditions
- Neuropsychiatric Disorders
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Increased screening for hepatitis C virus among people with serious mental illness is key to achieving global eradication of the virus.
- Eating Disorders
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Night eating syndrome is a condition that requires early identification and management, especially among adolescents who develop symptoms during the transition into adulthood.
- Psychotic Disorders
- Veterans and Military Issues
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Measurement-based care (MBC) can improve patient outcomes, but data on its use in psychosis are sparse. This study examined the use of patient-reported outcome measures in veterans with psychosis to identify candidate measures for psychosis-related MBC.
- Alzheimer Disease
- Dementia
- Neuroimaging
- Primary Care
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
$0.00
Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in the field.
- Alzheimer Disease
- Dementia
- Integrated Care
- Neuroimaging
- Patient/Physician Communication
- Primary Care
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
$0.00
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
- Renal Disease
- Adherence
- Cardiology
- Comorbidity
- Diagnostic Tools
- Education
- Medical Conditions
- Primary Care
- Side Effects
- Weight
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.